Free press releases distribution network?

Agency / Source: IMI Publishing Ltd

Check Ads Availability|e-mail Article


Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!



20/20 Pharma Announces Live Expert Discussion on Patient Recruitment - A look at patient recruitment in this executive interview with Pfizer’s Craig Lipset and Dr Rick Malcolm of Acurian, a leading company in the field of patient recruitment - 2020Pharma.com
20/20 Pharma Announces Live Expert Discussion on Patient Recruitment

 

PRZOOM - /newswire/ - London, United Kingdom, 2011/07/05 - A look at patient recruitment in this executive interview with Pfizer’s Craig Lipset and Dr Rick Malcolm of Acurian, a leading company in the field of patient recruitment - 2020Pharma.com.

   
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Industry experts go head to head in 20/20 Pharma’s ‘Advancing patient recruitment’ podcast discussion. Patient recruitment is an essential element to clinical trials and this discussion gives audiences a look at patient recruitment today.

The podcast is moderated by Craig Lipset, Pfizer’s Head of Clinical Innovation, Development Operations, Worldwide Research & Development, who is joined by Dr Rick Malcolm, Chief Executive Officer of Acurian.

The podcast is an insightful analysis of patient recruitment and includes comments on:

- The challenges patient recruitment brings to clinical trials;
- Myths and misconceptions of patient recruitment;
- Opportunities in electronic health data;
- E-patients fitting into clinical trials;
- Budgeting for patient recruitment;
- Forecasting the future of clinical trials.

In the podcast Rick Malcolm said: “Over the years we have sent letters and contacted millions of people about participation in clinical trials and as you know it is highly regulated.

“We have hundreds of thousands of people in the United States that respond to these invitations that have an interest in participating in clinical trials.”

He also commented: “On a regular basis, an increasing number of physicians and healthcare systems are doing more and more with electronic health records, which certainly holds out the possibility to be even more targeted in who you reach out to.”

For more information and topical pharmaceutical related podcasts visit the webstie.

About 20/20 Pharma
20/20 Pharma (2020pharma.com) is a product of IMI Publishing Ltd, dedicated to offering its clients and partners a unique opportunity to not only advertise the capabilities of their companies, but also showcase their technology or services through in-depth educational pieces and targeted online events.
Dedicated to being a trusted and authoritative resource within top pharmaceutical companies, as well as small, specialty and biotech businesses, 20/20 Pharma bridges the gap between the industry’s top issues and the solutions that top-tier vendors can provide.

 
 
Your Banner Ad Here instead - Showing along with ALL Articles covering Pharma/BioTech/Nutrition Announcements

Replace these Affiliate Programs at ANYTIME! Your banner here within the next hour. Learn How!


 

Agency / Source: IMI Publishing Ltd

 
 

Availability: All Regions (Including Int'l)

 

Traffic Booster: [/] Quick PRZOOM - Press & Newswire Visibility Checker

 

Distribution / Indexing: [+]

 
 
# # #
 

 
  Your Banner Ad showing on ALL
Pharma/BioTech/Nutrition articles,
CATCH Visitors via Your Competitors Announcements!


20/20 Pharma Announces Live Expert Discussion on Patient Recruitment

Company website links NOT available to basic submissions
It is OK to republish and/or LINK any newswire for any legitimate media purpose as long as you name PRZOOM - Press & Newswire and LINK as the source.
 
  For more information, please visit:
Is this your article? Activate ALL web links by Upgrading to Press Release PREMIUM Plan Now!
|
Contact: Pinar Gencturk - IMIpublishing.com 
+44 207 148 5152 pgencturk[.]imipublishing.com
 
PRZOOM / PRTODAY - Newswire Today disclaims any content contained in this article. If you need/wish to contact the company who published the current release, you will need to contact them - NOT us. Issuers of articles are solely responsible for the accuracy of their content. Our complete disclaimer appears here.
IMPORTANT INFORMATION: Issuance, publication or distribution of this press release in certain jurisdictions could be subject to restrictions. The recipient of this press release is responsible for using this press release and the information herein in accordance with the applicable rules and regulations in the particular jurisdiction. This press release does not constitute an offer or an offering to acquire or subscribe for any IMI Publishing Ltd securities in any jurisdiction including any other companies listed or named in this release.

Pharma/BioTech/Nutrition via RSSAdd NewswireToday - PRZOOM Headline News to FeedBurner
Find who RetweetFollow @NewswireTODAY



Are you the owner of this article?, Turn it PREMIUM with your LOGO instead - and make it 3rd party Ads-Free! within the next hour!




Read Latest Press Releases From IMI Publishing Ltd / Company Profile


Read Pharma/BioTech/Nutrition Most Recent Related Press Releases:

Frost & Sullivan Commends Nemaura for Developing Superior Transdermal Drug Delivery Technology Platforms, the Memspatch and Micropatch
Greenphire Sponsors Second Annual Clinical Trial Agreements, Investigator Payments and Fair Market Value Meeting
Genentech’s Gazyva Helped People with Previously Untreated Follicular Lymphoma Live Significantly Longer
BD Announces Adoption of Windows 10 ‘Internet of Things’ for the Pyxis™ ES System
Greenphire Named to Deloitte 2016 Technology Fast 500™
Genentech Showcases New Clinical Data Across a Variety of Blood Diseases at American Society of Hematology 2016 Annual Meeting
BD Collaborates with JDRF to Focus on Extended Wear Innovations for Insulin Infusion Delivery
BD Launches First Syringe Designed for Use with Humulin® R U-500 Insulin
MDxHealth Announces Unique CPT Code Awarded for ConfirmMDx from the American Medical Association
BD MAX™ Vaginal Panel Receives FDA Market Authorization to Detect Most Common Causes of Vaginal Infections

Boost Your Social Network
& Crowdfunding Campaigns


LIFETIME SOCIAL MEDIA WALL
 
NewswireToday Celebrates 10 Years in Business
Find business coaching, life coaching, executive coaching and corporate coaching, best selling coaching books, ...



PREMIUM Members


Visit  Triggr & Bloom

Visit  BizJobs.com

Visit  JobsWare.com







 
  ©2016 PRZOOM — Limelon Advertising, Co.
Home | About PRZOOM | Advertise/Pricing | Contact | Investors | Privacy/TOS | Sitemap | FRANCAIS
newswire, PR free press releases distribution service magazines engine news alert newsroom press room breaking news public relations articles company news alerts newswiredistribution ezine bizentrepreneur biznewstoday digital business report market search pr firms agencies reports distri-bution today investor relation successful internet entrepreneur newswire distribution prtoday.com freenewswiredistribution asianewstoday bizwiretoday USA pr UK today